Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus

23 Feb 2024

Abstract excerpt

Infectious bursal disease (IBD), caused by IBD virus (IBDV), is an extremely contagious immunosuppressive disease that causes major losses for the poultry industry worldwide. Recently, the novel variant IBDV (G2d) has been highly prevalent in Korea, but the current vaccines against this very virulent IBDV have limited efficacy against this novel variant. To develop a vaccine against this variant IBDV, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38543860
DOI: 10.3390/vaccines12030226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease VirusPMID 38543860Read ↗

A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 systemSemantic proximity Read ↗

A reassortment vaccine candidate of the novel variant infectious bursal disease virus.Semantic proximity Read ↗

Construction and immune efficacy of a recombinant turkey herpesvirus vaccine strain expressing fusion protein of genotype VII Newcastle disease virus.Semantic proximity Read ↗

Recombinant Marek’s disease virus expressing VP1 and VP2 proteins provides robust immune protection against chicken infectious anemia virusSemantic proximity Read ↗

Generation of A Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene EditingSemantic proximity Read ↗

Co-expression of IBDV VP2 and H9N2 HA by recombinant HVT induces high protection against both pathogens in chickensSemantic proximity Read ↗

Development of a recombinant VP2 vaccine for the prevention of novel variant strains of infectious bursal disease virusSemantic proximity Read ↗

Epidemiological characteristics of infectious bursal disease virus (IBDV) in China from 2023 to 2024: Mutated very virulent IBDV (mvvIBDV) is associated with atypical IBDSemantic proximity Read ↗

The Over-40-Years-Epidemic of Infectious Bursal Disease Virus in China.Semantic proximity Read ↗

Immune efficacy of two recombinant Turkey herpesviruses expressing the fusion protein of Newcastle disease virus genotype VII and hemagglutinin protein of H9N2 avian influenza virus generated by HDR/NHEJ-CRISPR/Cas9 systems.Semantic proximity Read ↗

A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens.Semantic proximity Read ↗

Isolation and genomic characteristics of the novel variant infectious bursal disease virus in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.